Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -7.46
- Piotroski Score 2.00
- Grade Buy
- Symbol (OCX)
- Company OncoCyte Corporation
- Price $2.65
- Changes Percentage (1.53%)
- Change $0.04
- Day Low $2.65
- Day High $2.69
- Year High $4.34
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $10.00
- High Stock Price Target $10.00
- Low Stock Price Target $4.25
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$5.32
- Trailing P/E Ratio -0.52
- Forward P/E Ratio -0.52
- P/E Growth -0.52
- Net Income $-27,781,000
Income Statement
Quarterly
Annual
Latest News of OCX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
OCX Stock Price | Oncocyte Corp. Stock Quote (U.S.: Nasdaq) | MarketWatch
OncoCyte Corp. is a molecular diagnostics company specializing in developing and selling cancer detection tests like DetermaRx and DetermaIO. It also offers molecular diagnostic services to pharmaceut...
By MarketWatch | 5 months ago
